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Effects of Repetition and Rate/Rhythm Treatments for Acquired Apraxia of Speech 
 
Numerous therapies have been shown to have positive effects in the treatment of acquired 
apraxia of speech (AOS) (Wambaugh, Duffy, McNeil, Robin, & Rogers, 2006).  All of the 
treatments that have been developed for AOS have been comprised of a combination of 
techniques (Wambaugh et al.). Only recently have investigators begun to examine components of 
treatment (e.g., Austerman Hula, Robin, Maas, Ballard, & Schmidt, 2008) or to compare 
treatments (Brendel & Ziegler, 2008; Rose & Douglas, 2006).   
An element of treatment that is common to all AOS therapies is repeated practice 
(Wambaugh et al., 2006). Repeated practice has been demonstrated to be a critical aspect of 
nonspeech motor learning (Schmidt & Lee, 2005), and is likely to be crucial in the rehabilitation 
of AOS.  Additionally, if treatments or treatment components are to be compared, it is important 
to understand the contribution of repeated practice to treatment effects. 
The purpose of this investigation was to examine the effects of repeated practice 
treatment on sound production accuracy in speakers with AOS.  The study was also designed to 
determine if the addition of rate/rhythm control to treatment provided further benefits (after 
maximal improvements were achieved with repeated practice treatment).  
Five speakers with chronic AOS and agrammatic aphasia served as participants. Findings 
from five other participants with AOS were reported previously (presentation reference omitted 
for anonymity) and this investigation represents additional indirect replications. Previous 
findings indicated strong positive effects of repetition treatment for all participants with limited 
additional benefits from the addition of rate/rhythm treatment.  
 
Method 
Participants 
 Five adults with chronic, moderate AOS and agrammatic aphasia served as participants. 
All demonstrated speech behaviors that were consistent with AOS diagnostic criteria described 
by McNeil et al. (1997; 2009). The participants were native-English speakers, passed hearing 
screenings and demonstrated performance within normal limits on a test of nonlinguistic 
intelligence.  
As shown in Table 1, all participants were male, ranged in age from 33 to 60 years and 
were 15 to 357 months post stroke.  
 
Experimental Design 
A combined ABCA and multiple baseline across behaviors and subjects design was 
employed with each participant.   
The experimental design was selected to allow examination of the effects of repetition 
treatment alone, with treatment continuing until maximum gains were achieved. Following a 
period of five probe sessions with no additional improvements, rate/pacing treatment was 
combined with repetition treatment to determine if additional improvements could be obtained.  
For each participant, five lists of target items were devised and randomly assigned to the 
following conditions: 
List 1 – repetition treatment, then rate/pacing control plus repetition treatment  
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List 2 – repetition treatment only, simultaneously with Set 1 
List 3 – repetition treatment, then rate/pacing control plus repetition treatment; application 
delayed  
List 4 – no treatment, probed daily  
List 5 – no treatment, probed at end of treatment phases 
 Following a baseline phase (A), repetition treatment (B) was initiated with Sets 1 and 2. 
Treatment continued until pre-established criteria were met. Rate control plus repetition 
treatment (C) was then applied with Set 1 while repetition treatment only continued with Set 2. 
Then the preceding treatment sequence (B - C) was applied with Set 3, with repetition treatment 
continuing with Set 2.  
Follow-up probes were completed at 4 and 8 weeks after cessation of all treatment. 
Please note that P10 is currently completing the final phase of treatment.  
 
Experimental Stimuli 
 Experimental stimuli were as follows: P6  - bi-and trisyllabic words  with word initial 
clusters and word final fricatives/affricates,  P7 (E)  - ; P8  (P) - ; P9 - bi- and trisyllabic words 
containing clusters, and P10 – bi- and trisyllabic words containing clusters.  
All lists were carefully selected and balanced for each participant and will be described in 
more detail for the presentation. There were 20 items per list for each participant.   
 
Dependent Measures 
 Probes of accuracy of production of target items were conducted in baseline and 
throughout the treatment phases. The items in each set were randomized and the participant was 
asked to produce the word as accurately as possible following the examiner’s model. No 
feedback or instruction was provided during probes. Productions were scored for accuracy on-
line and were audio-recorded for verification purposes. Percentage of accuracy was calculated 
for each set of items. Probes were conducted at the start of daily sessions, prior to the application 
of treatment for the day.  
Treatment 
 Repetition treatment consisted of presenting the target item verbally and requesting the 
participant to produce the item 5 times in succession. Only general feedback about the accuracy 
of the grouped productions was provided (e.g., “those all sounded perfect”, “there were a few 
sound errors”, etc.). 
Rate/pacing control treatment entailed provision of a verbal model of the item by the 
examiner and repeated practice (as above) of the item with hand-tapping in time to a metronome. 
The metronome was set to a rate that approximated a fifty percent reduction in the participant’s 
typical rate of production. Again, only general feedback was provided. 
 In each treatment session, two sets of stimuli underwent treatment. The order in which 
the sets were submitted to treatment was counterbalanced. The 20 items in the treatment set were 
presented in random order, with this process completed a total of three times. Then a 10-30 
minute break was taken prior to treatment being applied with the remaining set.  
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 Treatment was continued in each phase until 1) 90% accuracy in two consecutive probe 
sessions was achieved, or 2) no gains were achieved for five probe sessions following the highest 
level of probe performance (if at least 10 treatment sessions had been completed).  
 Additionally, if performance reached at least 85% accuracy with repetition treatment 
only, then rate/pacing treatment was not applied (i.e., the “C” phase was omitted for that set of 
items).  
Results 
 Results are shown Figures 1 – 5 for Participants 6 – 10.  The plotted data in each graph 
represent accuracy of production of target items for that list during probes. Effect sizes were 
calculated for each phase of treatment and d-index statistics are displayed on the graphs.  
 For the repetition treatment phases, Participants 7, 8, and 9 demonstrated clear gains in 
accuracy of articulation for all applications, with effect sizes ranging from d=3.75 to d=12.7. 
Participants 6 and 10 demonstrated minimal improvements with the application of repetition 
treatment, although modest positive effect sizes were achieved (i.e., d=1.59 – d= 4.35).  
 No additional gains were observed with application of rate/rhythm treatment for 
Participants 6 and 10. However, Participants 7 and 9 achieved additional gains with the addition 
of rate/rhythm treatment (d=1.97 – d=3.8).  Participant 8 did not receive rate/rhythm treatment 
because he achieved at least 85% accuracy of production with repetition treatment alone.  
 Gains of approximately 30% and 40% accuracy were observed for Participants 7 and 9, 
respectively, for the untreated items that were probed frequently (List 4 items). The other 
participants did not demonstrate gains with the untreated, frequently exposed list.  
 Improvements in production of untreated items in the lists that received limited probing 
(i.e., List 5), were minimal for all participants.  
 
Discussion 
 
 Findings for three of the participants were similar to our previously reported results. 
However, different results were found for two participants, who demonstrated minimal gains 
with both repeated practice treatment and rate/rhythm control. Positive and negative treatment 
effects will be discussed relative to participant characteristics and models of speech 
learning/production.  
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Table 1 
 Participant Descriptive Data 
Participant Gender Etiology Age MPO WAB- 
AQ 
PICA -
Overall 
Aphasia 
Type-WAB 
P6  M CVA 60 124 51.6 47
th 
 %ile Broca’s 
P7  M CVA 54 35 64.8 55th  %ile Broca’s 
P8  M CVA 33 15 24.8 40th  %ile Broca’s 
P9  M CVA 56 28 73.7 66
th
  %ile Broca’s 
P10  M CVA 52 357 40.6 43
rd
  %ile Broca’s 
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Figure 1. Accuracy of production of target items in probes for Participant 6.  
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Participant 7
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Figure 2. Accuracy of production of target items in probes for Participant 7. 
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Participant 8
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Figure 3. Accuracy of production of target items in probes for Participant 8.  
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Participant 9
0 5 10 15 20 25 30 35 40 45 50 55 60
L
is
t 
1
 -
 %
 C
o
rr
e
ct
0
20
40
60
80
100
0 5 10 15 20 25 30 35 40 45 50 55 60
L
is
t 
2
 -
 %
 C
o
rr
e
ct
0
20
40
60
80
100
0 5 10 15 20 25 30 35 40 45 50 55 60
L
is
t 
3
 -
 %
 C
o
rr
e
ct
0
20
40
60
80
100
0 5 10 15 20 25 30 35 40 45 50 55 60
L
is
t 
4
 -
 %
 C
o
rr
e
ct
0
20
40
60
80
100
Probe Sessions
0 5 10 15 20 25 30 35 40 45 50 55 60
L
is
t 
5
 -
 %
 C
o
rr
e
ct
0
20
40
60
80
100
Baseline (A) Repetition Tx. (B) Rate/Rhythm Tx. (C)
A
Repetition Tx. (B)
A Repetition Tx. (B) Rate/Rhythm Tx. (C)
d=7.38 d=3.8
d=12.7
d=3.75 d=2.12
Figure 4. Accuracy of production of target items in probes for Participant 9.  
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Participant 10
0 5 10 15 20 25 30
L
is
t 
1
 -
 %
 C
o
rr
e
c
t
0
20
40
60
80
100
0 5 10 15 20 25 30
L
is
t 
2
 -
 %
 C
o
rr
e
c
t
0
20
40
60
80
100
0 5 10 15 20 25 30
L
is
t 
3
 -
 %
 C
o
rr
e
c
t
0
20
40
60
80
100
0 5 10 15 20 25 30
L
is
t 
4
 -
 %
 C
o
rr
e
c
t
0
20
40
60
80
100
Probe Sessions
0 5 10 15 20 25 30
L
is
t 
5
 =
 %
 C
o
rr
e
c
t
0
20
40
60
80
100
Baseline (A) Repetition Tx. (B) Rate/Rhythm Tx. (C)
A Repetition Tx. (B)
d=1.59 d=-0.34
d=1.89
  
Figure 5. Accuracy of production of target items in probes for Participant 10.  
